Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled...
Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19
Atea Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from...
CureVac Reports Positive Interim Phase 1 Data for its COVID-19 Vaccine Candidate, CVnCoV
CureVac N.V. a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced positive interim data from...
EC approves Roches Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
Roche announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or...
U.S. FDA Approves Gileads Antiviral Veklury (remdesivir) for Treatment of COVID-19
Gilead Sciences, Inc. announced that the U.S. FDA has approved the antiviral drug Veklury for the treatment of patients with COVID-19 requiring hospitalization. As...
Lilly and Incyte Highlight Positive Data for Olumiant in Rheumatoid Arthritis
Eli Lilly and Company and Incyte announced positive data for Olumiant will be presented at ACR Convergence 2020, the American College of Rheumatology's virtual...
Novartis sickle cell medicine Adakveo approved in Europe to prevent recurrent vaso-occlusive crises
Novartis announced that the European Commission (EC) has approved Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or pain crises, in patients...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...